110 related articles for article (PubMed ID: 2074245)
1. Efficacy and tolerance of cefodizime in the treatment of acute pyelonephritis.
Kourilsky O
J Antimicrob Chemother; 1990 Nov; 26 Suppl C():111-6. PubMed ID: 2074245
[TBL] [Abstract][Full Text] [Related]
2. An open multicentre study of the efficacy and tolerance of cefodizime 1 g bd intravenously or intramuscularly in lower respiratory tract infections.
Sollet JP
J Antimicrob Chemother; 1990 Nov; 26 Suppl C():103-10. PubMed ID: 2074244
[TBL] [Abstract][Full Text] [Related]
3. [Effectiveness and tolerance of cefixime in the treatment of acute pyelonephritis].
Weissbach L; Segal A; Tröster K
Infection; 1990; 18 Suppl 3():S140-4. PubMed ID: 2079374
[TBL] [Abstract][Full Text] [Related]
4. Clinical safety profile of cefodizime.
Perianu MR
J Antimicrob Chemother; 1990 Nov; 26 Suppl C():127-34. PubMed ID: 2074247
[TBL] [Abstract][Full Text] [Related]
5. A randomized, dose comparison study of cefodizime in the treatment of lower urinary tract infections in women.
Asbach HW
Infection; 1991; 19(2):85-7. PubMed ID: 2050425
[TBL] [Abstract][Full Text] [Related]
6. Cefodizime: the Japanese clinical experience.
Matsumoto K
Infection; 1992; 20 Suppl 1():S31-5. PubMed ID: 1526674
[TBL] [Abstract][Full Text] [Related]
7. Randomized comparative study of 0.5 and 1 g of cefodizime (HR 221) versus 1 g of cefotaxime for acute uncomplicated urogenital gonorrhea.
van der Willigen AH; Wagenvoort JH; Schalla WO; Knapp JS; Boot JM; Heeres-Weststrate PL; Michel MF; van Klingeren B; Stolz E
Antimicrob Agents Chemother; 1988 Apr; 32(4):426-9. PubMed ID: 3377456
[TBL] [Abstract][Full Text] [Related]
8. Cefodizime once daily in the treatment of lower respiratory tract infections.
Piovano CF; Palombini BC; Dagrosa EE; Mendoza F; Facco EB
Arzneimittelforschung; 1997 May; 47(5):674-7. PubMed ID: 9205786
[TBL] [Abstract][Full Text] [Related]
9. Cefodizime given once daily for the treatment of upper urinary tract infections and complicated lower urinary tract infections.
Hofstetter AG
Infection; 1992; 20 Suppl 1():S18-21. PubMed ID: 1526670
[TBL] [Abstract][Full Text] [Related]
10. [Clinical evaluation of cefmenoxime in urinary tract and prostatic infections].
Guibert J; Acar JF; Destree D; Bryskier A
Pathol Biol (Paris); 1985 May; 33(5):330-4. PubMed ID: 3897962
[TBL] [Abstract][Full Text] [Related]
11. Cefodizime and cefotaxime in acute exacerbations of chronic bronchitis: a randomized double-blind prospective study in 180 patients.
Maesen FP; Davies BI; van den Bergh JJ; Gubbelmans HL; Meek JC; Geraedts WH
J Antimicrob Chemother; 1990 Mar; 25(3):413-22. PubMed ID: 2187013
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacokinetic and clinical studies on cefodizime in the pediatric field. Pediatric Study Group of Cefodizime].
Fujii R; Arimasu O; Meguro H; Hiruma F; Sugie N; Abe T; Nakazawa S; Sato H; Narita A; Matsumoto K
Jpn J Antibiot; 1989 May; 42(5):1173-93. PubMed ID: 2664256
[TBL] [Abstract][Full Text] [Related]
13. Cefodizime (HR221) versus norfloxacin for treatment of urinary tract infections.
Esposito S; Sardaro C; Gaeta GB; Galante D; Giusti G; Basani F
J Chemother; 1991 Feb; 3(1):42-4. PubMed ID: 2019862
[TBL] [Abstract][Full Text] [Related]
14. [Clinical evaluation and immunomodulatory study of cefodizime].
Li G; Zhang Y; Ji M
Zhonghua Nei Ke Za Zhi; 1997 Nov; 36(11):759-63. PubMed ID: 10451950
[TBL] [Abstract][Full Text] [Related]
15. [Bacteriological and clinical studies of cefodizime in pediatrics].
Akita H; Sato Y; Iwata S; Sunakawa K
Jpn J Antibiot; 1991 Apr; 44(4):398-411. PubMed ID: 1880919
[TBL] [Abstract][Full Text] [Related]
16. Randomized comparative study of cefepime and cefotaxime in the treatment of acute obstetric and gynaecological infections.
Newton ER; Yeomans ER; Pastorek JG; Soper DE; Hemsell DL
J Antimicrob Chemother; 1993 Nov; 32 Suppl B():195-204. PubMed ID: 8150763
[TBL] [Abstract][Full Text] [Related]
17. [Ciprofloxacin and cefotaxim: pharmacokinetic and therapeutic effectiveness in E. coli pyelonephritis in rats].
Tietgen K; Schulz E; Boness J; Marre R
Immun Infekt; 1986 Jul; 14(4):152-5. PubMed ID: 2943665
[TBL] [Abstract][Full Text] [Related]
18. Cefodizime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Barradell LB; Brogden RN
Drugs; 1992 Nov; 44(5):800-34. PubMed ID: 1280568
[TBL] [Abstract][Full Text] [Related]
19. Cefodizime given in single or divided doses for the treatment of lower respiratory tract infection.
Palombini BC; André-Alves MR; Dagrosa EE
Arzneimittelforschung; 1997 Mar; 47(3):299-302. PubMed ID: 9105549
[TBL] [Abstract][Full Text] [Related]
20. [Clinical experience with cefodizime in bacterial infection of children].
Yokota I; Takeda E; Kuroda Y
Jpn J Antibiot; 1989 Jun; 42(6):1385-90. PubMed ID: 2795862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
